Stem Cell Therapy
Stem cell therapy is the process of injecting stem cells into an organism or person in the hope that they will differentiate and replace damaged tissue, or to repair specific tissues or to grow organs.
Stem Cell Therapy - most related articles:
-
Stem cell therapy may prove valuable in paralysis - 9.3
-
2 types of stem cells are similar - 7.2
-
US Stem Cell Bank has received all 21 cell lines - 6.6
-
Stem cell funding for Parkinson's Disease - 6.5
-
Graying hairs are signs of stress - 6.4
-
BIO welcomes advances in stem cell research - 6.2
-
US cancer group AACR supports NIH stem cell research - 6.1
-
Stem cell therapy offers hope for acute lung injury - 6
-
UCL–Pfizer to develop stem cell sight therapies - 6
-
US can continue to fund embryonic stem cell research - 6
Stem Cell Therapy articles
Understanding beginnings of embryonic stem cells helps predict the futureOrdinarily, embryonic stem cells exist only a day or two as they begin the formation of the embryo itself. Then they are gone. In the laboratory dish, however, they act more like perpetual stem cells – renewing themselves and exhibiting the ability to form cells of almost any type, a status called totipotency.
Neural stem cell transplant may cure diabetesResearchers in Japan have discovered how a patient's neural stem cells could be used as an alternative source of the beta cells needed for a regenerative treatment for diabetes.
2 types of stem cells are similarResearchers saw substantial similarity between the two stem-cell types - pluripotent stem cells and embryonic stem cells, reported in a new study.
US can continue to fund embryonic stem cell researchThe American Society for Cell Biology (ASCB) applauds the decision of Judge Royce Lamberth of the U.S. District Court for the District of Columbia (DC) to dismiss a lawsuit challenging the U.S. National Institutes of Health guidelines on funding human embryonic stem cell research (hESC).
SOX2 gene acts as a stem cell gatekeeper, decides neural stem cell fateEarly in embryonic development, the neural crest – a transient group of stem cells – gives rise to parts of the nervous system and several other tissues. But little is known about what determines which cells become neurons and which become other cell types.
Stem cells repair heart damage in a human trialResearchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue and improved function to injured heart areas, according to a small trial published in Circulation Research: Journal of the American Heart Association.
Stem cells take cues from CSF fluid in brainProteins in fluids bathing the brain are essential for building the brain, revealed by researchers in the journal Neuron. The finding promises to advance research related to neurological disease, cancer and stem cells.
Skin cells converted to beating heart cellsAdult skin cells are converted into beating heart cells efficiently without generating embryonic-like stem cells, revealed by researchers.
Clinical trial of human embryonic stem cell therapy in USGeron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1.
Stem cells shape up to their surroundingsMany scientists aspire to take control over the stem cell differentiation process, so that we can grow organs and implants perfectly matched to each patient in the future.
US to continue stem cell researchAn appeals court in US allowed the government to resume funding human embryonic stem cell research while the court reviews whether it violates a ban by Congress on spending taxpayer money for experiments.
US cancer group AACR supports NIH stem cell researchThe American Association for Cancer Research (AACR), the world's oldest and largest cancer research organization, reiterates its support for the responsible conduct of human embryonic stem cell research that, up until this week, was funded by the National Institutes of Health (NIH) and expresses concern that the recent Federal District Court injunction to block federal funding for human embryonic stem cell research is a setback for scientific discovery.
Unproven stem cell therapies marketed on InternetLeading stem cell researchers from institutions around the world are issuing warnings about unproven stem cell therapies being marketed on the Internet and have launched a website to educate and protect patients seeking such treatments.
Early clamping may interrupt humankind's first natural stem cell transplantThe timing of umbilical cord clamping at birth should be delayed just a few minutes longer, suggest researchers at the University of South Florida's Center of Excellence for Aging and Brain Repair.
Ear's sensory hair cells made from stem cellsResearchers have found a way to coax embryonic stem cells as well as reprogrammed adult cells to develop into sensory cells that normally reside in the mammalian inner ear. Those mechanosensitive sensory hair cells are the linchpin of hearing and balance.
New tool illuminates connections between stem cells and cancerResearchers have a new tool to understand how cancers grow -- and with it a new opportunity to identify novel cancer drugs. They've been able to break apart human prostate tissue, extract the stem cells in that tissue, and alter those cells genetically so that they spur cancer.
Vitamin C boosts reprogramming of adult cells into stem cellsFamous for its antioxidant properties and role in tissue repair, vitamin C is touted as beneficial for illnesses ranging from the common cold to cancer and perhaps even for slowing the aging process.
Embryonic stem cell lines lack genetic diversityThe most widely used human embryonic stem cell lines lack genetic diversity, a finding that raises social justice questions that must be addressed to ensure that all sectors of society benefit from stem cell advances, according to a University of Michigan research team.
Stem cells may rescue vision in AMD patientsAn international team of scientists has rescued visual function in laboratory rats with eye disease by using cells similar to stem cells. The research shows the potential for stem cell-based therapies to treat age-related macular degeneration in humans.
New stem cell technology for complicated bone fracturesResearchers have developed a new way of using stem cells to provide better and rapid healing for patients suffering from complicated bone fractures.
Stem cells to create new skin for patients with burns and skin diseasesResearchers has succeeded in recreating a whole epidermis from human embryonic stem cells, revealed in a new study conducted by Marc Peschanski of INSERM published in the Lancet.
Stem cell therapy offers hope for acute lung injuryAdult stem cells from bone marrow can prevent acute lung injury in a mouse model of the disease, revealed by researchers at the University of Illinois at Chicago College of Medicine.
Controlled development of stem cells may lead to new stem cell therapiesInvestigators at the Burnham Institute for Medical Research (Burnham) and The Scripps Research Institute (TSRI) have made the first comparative, large-scale phosphoproteomic analysis of human embryonic stem cells (hESCs) and their differentiated derivatives.
New iPS therapy pioneered for heart attacksInduced pluripotent stem (iPS) cells can be used to treat heart disease, revealed by researchers at Mayo Clinic, USA. iPS cells are stem cells converted from adult cells.
Early stem cell transplant best for acute myeloid leukemia patientsA stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.
Stem cells improve sight for sore eyesIn a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.
Stem cell protein LIN28 offers a new cancer targetA protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
Stem cell - gene therapy may cure human genetic diseasesA study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology.
Embryo's heartbeat drives blood stem cell formationBiologists have long wondered why the embryonic heart begins beating so early, before the tissues actually need to be infused with blood. Two groups of researchers from Children's Hospital Boston, Brigham and Women's Hospital, and the Harvard Stem Cell Institute (HSCI) -– presenting multiple lines of evidence from zebrafish, mice and mouse embryonic stem cells -– provide an intriguing answer: A beating heart and blood flow are necessary for development of the blood system, which relies on mechanical stresses to cue its formation.
Multiple sclerosis treatment from fat stem cellsA preliminary study on the use of stem cells obtained from a patient's own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results.
UCL–Pfizer to develop stem cell sight therapiesUCL has entered into a collaboration with the biopharmaceutical group Pfizer, negotiated by UCL Business, to advance development of stem cell-based therapies for age-related macular degeneration (AMD).
Major advance in stem cell reprogramming technologyIn a paper publishing online April 23rd in Cell Stem Cell, a Cell Press journal, Dr. Sheng Ding and colleagues from the Scripps Research Institute in La Jolla, California, report an important step forward in the race to make reprogrammed stem cells that may be better suited for use in clinical settings.
Osteoporosis drug boost bone's healing processOsteoporosis drug teriparatide or Forteo can boost bodies' bone stem cell production to the point that adults' bones appear to have the ability to heal at a rate typically seen when they were young kids, revealed by researchers.
Stem cells may help stroke patientsEffective stem cell treatment for strokes has taken a significant step forward today as scientists reveal how they have replaced stroke-damaged brain tissue in rats.
Animal eggs not suitable to produce stem cellsSince the cloning of Dolly the Sheep over a decade ago, somatic cell nuclear transfer (SCNT) has been considered a promising way to generate human, patient-specific stem cells for therapeutic applications.
Human clinical trial of embryonic stem cell therapy approvedGeron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
US Stem Cell Bank has received all 21 cell linesThe U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden. With the addition of the new lines, the National Stem Cell Bank now has received all 21 cell lines from the six providers listed on the National Institutes of Health (NIH) federal registry.
Stem cells to repair the bodyScientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal Cell Stem Cell.
First embryonic stem cells from ratsResearchers at the University of Southern California (USC) have, for the first time in history, derived authentic embryonic stem (ES) cells from rats. This breakthrough finding will enable scientists to create far more effective animal models for the study of a range of human diseases.
International Society for Stem Cell Research releases new guidelinesThe International Society for Stem Cell Research (ISSCR), the world's leading professional organization of stem cell researchers, released new guidelines for the responsible development of safe and effective stem cell therapies for patients.
Transplant of trachea made from stem cells successfulThe first operation for transplantation of a tissue-engineered airway has been successful. This procedure has massively improved the quality of life of the 30-year-old Colombian female recipient who needed the transplant after contracting tuberculosis.
BIO welcomes advances in stem cell researchBiotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the news that researchers at the Harvard Stem Cell Institute created 20 disease-specific stem cell lines thru the new induced pluripotent stem cell (iPS) technique:
Stem cell therapy may prove valuable in paralysisAn amazing recovery noticed in an Australian Perry Cross who is quadriplegic, after regular injections of embryonic stem cells. Perry Cross was a rugby player and he got the paralysis of all his limbs in 1994 when he was 19 years old. Since then he was on ventilator to breath.
Cancer stem cells created with genes techniqueWith a bit of genetic trickery, researchers at the Stanford University School of Medicine have turned normal skin cells into cancer stem cells, a step that will make these naturally rare cells easier to study.
Stem cell funding for Parkinson's DiseaseThe Parkinson's Disease Society (PD) has announced funding of £170k to the University of Bristol for research into how to make stem cells produce dopamine and live longer after they have been transplanted into animals.
Stem cell therapy trials to mend shattered bonesScientists are developing a revolutionary way to mend damaged bones and cartilage using a patient's own stem cells.
Stem cells may improve muscles in muscular dystrophyUsing embryonic stem cells from mice, UT Southwestern Medical Center researchers have prompted the growth of healthy - and more importantly, functioning - muscle cells in mice afflicted with a human model of Duchenne muscular dystrophy. The study represents the first time transplanted embryonic stem cells have been shown to restore function to defective muscles in a model of muscular dystrophy.
Lhx2 creator gene for brain tissue repairUniversity of California, Irvine researchers have identified a gene that is specifically responsible for generating the cerebral cortex, a finding that could lead to stem cell therapies to treat brain injuries and diseases such as stroke and Alzheimer's.
Sickle cell anemia treated with stem cellsMIT researchers have successfully treated mice with sickle-cell anemia in a process that begins by directly reprogramming the mice's own cells to an embryonic-stem-cell-like state, without the use of eggs.
49 Stem Cell Therapy articles listed above.